Singapore markets closed

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
145.63-1.34 (-0.91%)
At close: 04:03PM EST
146.17 +0.54 (+0.37%)
After hours: 07:31PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 16.39B
Enterprise value 20.33B
Trailing P/E 14.12
Forward P/E 16.64
PEG Ratio (5 yr expected) 1.23
Price/sales (ttm)3.47
Price/book (mrq)2.63
Enterprise value/revenue 1.97
Enterprise value/EBITDA 9.22

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 37.86%
S&P500 52-week change 3-9.85%
52-week high 3158.34
52-week low 3120.40
50-day moving average 3150.21
200-day moving average 3138.31

Share statistics

Avg vol (3-month) 31.08M
Avg vol (10-day) 3963.75k
Shares outstanding 5113.89M
Implied shares outstanding 6N/A
Float 8112.86M
% held by insiders 10.72%
% held by institutions 195.33%
Shares short (12 Jan 2023) 43.3M
Short ratio (12 Jan 2023) 42.95
Short % of float (12 Jan 2023) 43.30%
Short % of shares outstanding (12 Jan 2023) 42.90%
Shares short (prior month 14 Dec 2022) 44M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 41.80%
Trailing annual dividend rate 32.60
Trailing annual dividend yield 31.77%
5-year average dividend yield 41.89
Payout ratio 425.52%
Dividend date 331 Jan 2023
Ex-dividend date 416 Jan 2023
Last split factor 22:1
Last split date 320 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 12.00%
Operating margin (ttm)18.23%

Management effectiveness

Return on assets (ttm)8.76%
Return on equity (ttm)20.40%

Income statement

Revenue (ttm)10.29B
Revenue per share (ttm)87.61
Quarterly revenue growth (yoy)-10.40%
Gross profit (ttm)4.24B
EBITDA 2.3B
Net income avi to common (ttm)1.23B
Diluted EPS (ttm)10.19
Quarterly earnings growth (yoy)-49.30%

Balance sheet

Total cash (mrq)700M
Total cash per share (mrq)6.15
Total debt (mrq)4.64B
Total debt/equity (mrq)73.08
Current ratio (mrq)1.46
Book value per share (mrq)54.69

Cash flow statement

Operating cash flow (ttm)1.86B
Levered free cash flow (ttm)1.25B